You are a helpful, respectful, and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information.
What is Palivizumab is a humanized monoclonal antibody. For which of the following conditions has it been approved for? and explain in detail?
d. Respiratory syncytial virus(Ref: Nelson 20/e p 1608)Drug Use in RSV infectionPalivhzumabIt is a monoclonal antibody licensed for prophylaxis in high-risk infants during the RSV season, and does prevent about half of the expected hospitalizations in that population.RibavirinIt is an antiviral agent delivered as an aerosol that showed a modest beneficial effect on the course of RSV pneumonia, with some reduction in the duration of both mechanical ventilation and hospitalization. However, latest studies have failed to document a clear beneficial effect of ribavirin, and therefore this drug is no longer used for routine therapy of RSV disease.